Unveiling EFNB2 as a Key Player in Sorafenib Resistance: Insights from Bioinformatics Analysis and Functional Validation in Hepatocellular Carcinoma
Crossref DOI link: https://doi.org/10.1007/s10528-024-10903-5
Published Online: 2024-08-30
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pan, Junli
Li, Quanxi
Zhu, Junli
Text and Data Mining valid from 2024-08-30
Version of Record valid from 2024-08-30
Article History
Received: 5 March 2024
Accepted: 7 August 2024
First Online: 30 August 2024
Declarations
:
: The authors declare no competing interests.